SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-032124
Filing Date
2017-06-12
Accepted
2017-06-12 16:05:07
Documents
3
Period of Report
2017-06-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v468313_8k.htm 8-K 37189
2 EXHIBIT 10.38 v468313_ex10x38.htm EX-10.38 75902
3 EXHIBIT 10.39 v468313_ex10x39.htm EX-10.39 94404
  Complete submission text file 0001144204-17-032124.txt   208900
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35366 | Film No.: 17906341
SIC: 2834 Pharmaceutical Preparations